Illegitimate expression of apolipoprotein A-II in Caco-2 cells is due to chromatin organization

Experimental Cell Research

Volumn 247, Issue 2, 1999, Pages 373-379

  Le Beyec, Johanne ^a   Ribeiro, Agnès ^a   Schreider, Cyrille ^a   Chambaz, Jean ^a   Rousset, Monique ^a   Pinçon Raymond, Martine ^a   Cardot, Philippe ^a  

^a INSERM   (France)

Author keywords

Apolipoprotein A II; Caco 2 cells; Chromatin; Glucose; Transcription

Indexed keywords

APOLIPOPROTEIN A2; APOLIPOPROTEIN A4; GLUCOSE;

ARTICLE; CELL DIFFERENTIATION; CELL STRAIN CACO 2; CHROMATIN; GENE CONTROL; GLUCOSE INTAKE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE;

EID: 0033558860     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4371     Document Type: Article

References (41)

1. Fielding C. J., Fielding P. E. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36:1995;211-228.
2. Banka C. L. High density lipoprotein and lipoprotein oxidation. Curr. Opin. Lipidol. 7:1996;139-142.
3. Eisenberg S. High density lipoprotein metabolism. J. Lipid Res. 25:1984;1017-1058.
4. Huang Y., Von Eckerstein A., Wu S., Assmann G. Cholesterol efflux, cholesterol esterification, and cholesteryl ester transfer by LpA-I and LpA-I/A-II in native plasma. Arterioscler. Thromb. Vasc. Biol. 15:1995;1412-1417.
5. Ikewaki K., Zech L. A., Kindt M., Brewer H. B. Jr., Rader D. J. Apolipoprotein A-II production rate is a major factor regulating the distribution of apolipoprotein A-I among HDL subclasses LpA-I and LpA-I: A-II in normolipidemic humans. Arterios. Thromb. Vasc. Biol. 15:1995;306-312.
6. Ikewaki K., Zech L. A., Brewer H. B. Jr., Rader D. J. ApoA-II kinetics in human using endogenous labeling with stable isotopes: Slower turnover of apoA-II compared with the exogenous radiotracer method. J. Lipid Res. 37:1996;399-407.
7. Hussain M. M., Zannis V. I. Intracellular modification of human apolipoprotein A-II (apo A-II) and sites of apo A-II mRNA synthesis: Comparison of apo A-II with apo C-II and apo C-III isoproteins. Biochemistry. 29:1990;209-217.
8. Hopkins B., Sharpe C. R., Barallele F. E., Grahan C. F. Organ distribution of apolipoprotein gene transcripts in 6-12 week postfertilization human embryos. J. Embryol. Exp. Morphol. 97:1986;177-187.
9. Knott T. J., Wallis S. C., Robertson M. E., Priestly L. M., Urdea M., Rall L. B., Scott J. The human apolipoprotein AII gene: Structural organization and sites of expression. Nucleic Acids Res. 13:1985;6387-6389.
10. Eggerman T. L., Hoeg J. M., Meng M. S., Tombragel A., Bojanovski D., Brewer H. B. Jr. Differential tissue-specific expression of human apo A-I and apo A-II. J. Lipid Res. 32:1991;821-828.
11. Le Beyec J., Benetollo C., Chauffeton V., Domiar A., Lafrenière M. J., Chambaz J., Cardot P., Kalopissis A. D. The -911/+29 sequence of human apolipoprotein A-II promoter is sufficient to confer liver restricted expression, development changes and response to a high fat diet. Transgenics. 2:1998;211-220.
12. Cardot P., Chambaz J., Cladaras C., Zannis V. I. Regulation of the human ApoA-II gene by the synergistic action of factors binding to the proximal and distal regulatory elements. J. Biol. Chem. 266:1991;11676-11685.
13. Lacorte J. M., Fourniat E., Pastier D., Chambaz J., Ribeiro A., Cardot P. The proximal element of the human apolipoprotein A-II promoter increases the enhancer activity of the distal region. Biochem. J. 318:1996;581-588.
14. Chambaz J., Cardot P., Pastier D., Zannis V. I., Cladaras C. Promoter elements and factors required for hepatic transcription of the human ApoA-II gene. J. Biol. Chem. 266:1991;11676-11685.
15. Bossu J.-P., Chartier F. L., Vu-Dac N., Fruchard J.-C., Laine B. Transcription of the human apolipoprotein A-II is down-regulated by the first intron of its gene. Biochem. Biophys. Res. Commun. 202:1994;822-829.
16. Zweibaum A., Laburthe M., Grasset E., Louvard D. Use of cultured cell lines in studies of intestinal cell differentiation and function. "Handbook of Physiology," Section 6, The Gastrointestinal System. 1991;Am. Physiol. Soc. Bethesda. p. 221-286.
17. Delie F., Rubas W. A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: Advantages and limitations of the Caco-2 model. Critical Reviews in Therapeutic Drug Carrier Systems. 1997;. p. 221-226.
18. Le Beyec J., Delers F., Jourdan F., Schreider C., Chambaz J., Cardot P., Pinçon-Raymond M. A complete epithelial organization of Caco-2 cells induces I-FABP and potentializes apolipoprotein gene expression. Exp. Cell Res. 236:1997;311-320.
19. Chantret I., Rodolosse A., Barbat A., Dussault E., Brot-Laroche E., Zweibaum A., Rousset M. Differential expression of sucrase-isomaltase in clones isolated from early and late passage of the cell line Caco-2: Evidence for glucose-dependent negative regulation. J. Cell Sci. 107:1994;213-225.
20. Mahraoui L., Rodolosse A., Barbat A., Dussaulx E., Zweibaum A., Rousset M., Brot-Laroche E. Presence and differential expression of SGLT1, GLUT1, GLUT2, GLUT3 and GLUT5 hexose-transporter mRNAs in Caco-2 cell clones in relation to cell growth and glucose consumption. Biochem. J. 298:1994;629-633.
21. Carrière V., Barbat A., Rousset M., Brot-Laroche E., Dussaulx E., Cambier D., De Waziers I., Beaune P., Zweibaum A. Regulation of sucrase-isomaltase and hexose transporters in Caco-2 cells: A role for cytochrome P-4501A1? Am. J. Physiol. (Gastrointest. Liver Physiol.). 270:1996;G976-G986.
22. Lopez J., Roghani A., Bertrand J., Zanni E., Kalopissis A. D., Zannis V. I., Chambaz J. Intracellular early and late modifications of human apolipoprotein A-II. Effect of glutamine- +1 to leucine substitution. Biochemistry. 33:1994;4056-4064.
23. Li Z., Marchand P., Humbert J., Babinet C., Paulin D. Desmin sequence elements regulating skeletal muscle-specific expression in transgenic mice. Development. 117:1993;947-959.
24. Graham F. L., van den Erb A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 52:1973;456-467.
25. Pinçon-Raymond M., Vicart P., Bois P., Chassandre O., Romey G., Varadi G., Li Z. L., Lazdunski M., Rieger F., Paulin D. Conditional immortalization of normal and dysgenic mouse muscle cells by the SV40 large T antigen under the vimentin promoter control. Dev. Biol. 148:1991;517-528.
26. Sanes J. R., Rubinstein J. L., Nicolas J. F. Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J. 5:1986;3133-3142.
27. Shapiro D. J., Sharp P. A., Wahli W. W., Keller M. J. A high-efficiency HeLa cell nuclear transcription extract. DNA. 7:1988;47-55.
28. Pinto M., Appay M. D., Simon-Assman P., Chevalier G., Dracopoli N., Fogh J., Zweibaum A. Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol. Cell. 44:1983;193-196.
29. Fesenfeld G. Chromatin as an essential part of the transcriptional mechanism. Nature. 355:1992;219-224.
30. Miller N. E. Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am. Heart J. 113:1987;589-597.
31. Trotter P. J., Storch J. Fatty acid esterification during differentiation of the human intestinal cell line Caco-2. J. Biol. Chem. 268:1993;10017-10023.
32. Wagner R. D., Krul E. S., Moberly J. B., Alpers D. H., Schonfeld G. Apolipoprotein expression and cellular differentiation in Caco-2 intestinal cells. Am. J. Physiol. 263:1992;E374-E382.
33. Ribeiro A., Pastier D., Kardassis D., Chambaz J., Cardot P. Cooperative binding of upstream stimulatory factor and hepatic nuclear factor 4 drives the transcription of the human apolipoprotein A-II gene. J. Biol. Chem. 274:1999;1216-1225.
34. Suaud L., Joseph B., Formstecher P., Laine B. mRNA expression of HNF-4 isoforms and of HNF-1α/HNF-1β variants and differentiation of human cell lines that mimics highly specialized phenotypes of intestinal epithelium. Biochem. Biophys. Res. Commun. 235:1997;820-825.
35. Rousset M., Laburthe M., Pinto M., Chevalier G., Rouyer-Fessard C., Dussaulx E., Trugnan G., Boige N., Brun J. L., Zweibaum A. Enterocytic differentiation and glucose utilization in the human colon tumor cell line Caco-2: Modulation by forskolin. J. Cell Physiol. 123:1985;377-385.
36. Diaz-Guerra M. J. M., Bergot M. O., Martinez A., Cuif M. H., Kahn A., Raymondjean M. Functional characterization of the L-type pyruvate kinase gene glucose response complex. Mol. Cell. Biol. 13:1993;7725-7733.
37. Violet B., Khan A., Raymondjean M. Protein kinase A-dependent phosphorylation modulates DNA-binding of hepatocyte nuclear factor 4. Mol. Cell. Biol. 17:1997;4208-4219.
38. Lefrançois-Martinez A.-M., Martinez A., Antoine B., Raymondjean M., Khan A. Upstream stimulatory factor proteins are major components of the glucose response complex of the L-type pyruvate kinase gene promoter. J. Biol. Chem. 270:1995;2640-2643.
39. Kaytor E. N., Shih H.-M., Towle H. C. Carbohydrate regulation of hepatic gene regulation. Evidence against a role for the upstream stimulatory. J. Biol. Chem. 272:1997;7525-7531.
40. Staels B., Auwerx J., Chan L., van Tol A., Rosseneu M., Verhoeven G. Influence of development, estrogens, and food intake on apolipoprotein A-I, A-II and E mRNA in rat liver and intestine. J. Lipid Res. 30:1989;1137-1145.
41. Zweibaum A. Differentiation of human colon cancer cells. Pharmaceuticals Applications of Cell and Tissue Culture to Drug Transport. 1991;Plenum Press, New York. p. 27-37.